Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1994-11-25
|
pubmed:abstractText |
A choline-deficient L-amino acid-defined (CDAA) diet led to the development of liver cirrhosis in 100% of male Wistar rats after 16 weeks. In contrast, an ordinary (semipurified) choline-deficient (CD) diet led to the development of liver cirrhosis in only 33.3%. After 16 weeks, the liver hydroxyproline content, which reflects the amount of collagen, increased to a level more than four times higher in rats fed a CDAA diet than in rats fed a choline-supplemented L-amino acid-defined (CSAA) diet. Concurrent administration of a prolyl 4-hydroxylase inhibitor, 2,4-pyridine dicarboxylic acid bis(2-methoxyethyl amide) (HOE 077), to rats fed a CDAA diet reduced this increase in liver hydroxyproline content in a dose-dependent manner for doses up to 200 p.p.m. Microscopically, reduction in the hydroxyproline content of the liver resulted in a reduced number of pseudolobuli and thinner fibrous septa. HOE 077 showed no effect on liver hydroxyproline content in rats fed a CSAA diet. The administration of a CDAA diet for 16 weeks led to a substantial induction of GSTP-positive lesions in the liver. The concurrent administration of HOE 077 reduced the number, average diameter and percent area of GSTP-positive lesions in a dose-dependent manner, in parallel with the reduction in hydroxyproline content. These data suggest that inhibition of fibrosis may limit the development of subsequent neoplasms.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Transferase,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyproline,
http://linkedlifedata.com/resource/pubmed/chemical/Procollagen-Proline Dioxygenase,
http://linkedlifedata.com/resource/pubmed/chemical/Prodrugs,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/lufironil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0143-3334
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2201-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7955054-Amino Acids,
pubmed-meshheading:7955054-Animals,
pubmed-meshheading:7955054-Choline Deficiency,
pubmed-meshheading:7955054-Diet,
pubmed-meshheading:7955054-Disease Models, Animal,
pubmed-meshheading:7955054-Glutathione Transferase,
pubmed-meshheading:7955054-Hydroxyproline,
pubmed-meshheading:7955054-Liver,
pubmed-meshheading:7955054-Liver Cirrhosis, Experimental,
pubmed-meshheading:7955054-Liver Neoplasms, Experimental,
pubmed-meshheading:7955054-Male,
pubmed-meshheading:7955054-Procollagen-Proline Dioxygenase,
pubmed-meshheading:7955054-Prodrugs,
pubmed-meshheading:7955054-Pyridines,
pubmed-meshheading:7955054-Rats,
pubmed-meshheading:7955054-Rats, Wistar
|
pubmed:year |
1994
|
pubmed:articleTitle |
Prevention of fibrosis reduces enzyme-altered lesions in the rat liver.
|
pubmed:affiliation |
First Department of Internal Medicine, School of Medicine, Yamaguchi University, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|